ARTICLE | Clinical News
Acusphere starts Phase II
January 31, 2000 8:00 AM UTC
Acusphere ( Cambridge, Mass.) began a Phase II trial of its AI-700 ultrasound contrast agent for assessing myocardial perfusion in patients with coronary artery disease. ...